Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 472 participants.
Also called NCT05910125
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 472 participants
- Registry
-
NCT05910125
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT05910125. Randomized; single masking; primary purpose treatment. Start 2023-07 (anticipated); primary completion 2027-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke
- Acronym
- AGREE
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Alteplase
- Lead sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Record details
- Record id
cardio:ct-nct05910125- Content hash
6c56fd7631e3d9d87bed8d1a757c77aac02f1de8c4b9b8bcee234282d421ce63